In addition, fibroblast growth factor receptor 3 (FGFR3) tyrosine kinase interacts with and activates TAK1 in MM cells, suggesting susceptibility of MM cells with t(4;14) to TAK1 inhibition [147]. This evidence concerns the gene FGFR3 and Miyoshi myopathy.